文献速递重症综合管理与镇静镇痛

基于个体化学习方法的危重症患者聚类可实现ICU早期活动的剂量优化

Clustering of critically ill patients using an individualized learning approach enables dose optimization of mobilization in the ICU.
PubMed 文献 · Crit Care · 2023-01-03
一句话结论在948例ICU患者中,人工智能聚类分出4个临床簇,各簇中能提高回家出院可能性的活动策略不同,可用于个体化活动处方。

本研究分析德国慕尼黑两个跨学科ICU的前瞻性观察数据库,纳入2017年4月至2019年5月的948例患者,采用k-means聚类基于入ICU时参数生成4个临床可定义簇:「年轻创伤」「重症衰弱」「老年非衰弱」「中年」。早期活动(<72 h)是「年轻创伤」簇回家出院的最重要因素(ORadj 10.0 [2.8–44.0],p<0.001);「中年」簇中回家出院可能性随每个活动等级增加,步行时最大增至24倍(ORadj 24.0 [7.4–86.1],p<0.001);「老年非衰弱」簇达到站立或步行时回家出院可能性显著增加(ORadj 4.7 [1.2–23.2],p=0.035和ORadj 8.1 [1.8–45.8],p=0.010)。作者认为不同簇对应不同活动策略,可实现个体化且资源优化的活动方案。

要点

  • 在「年轻创伤」簇中,早期活动(<72 h)是回家出院的最重要因素(ORadj 10.0 [2.8–44.0],p<0.001)。
  • 在「中年」簇中,回家出院可能性随每个活动等级增加,步行时最大增至24倍(ORadj 24.0 [7.4–86.1],p<0.001)。
  • 在「老年非衰弱」簇中,达到站立或步行时回家出院可能性显著增加(ORadj 4.7 [1.2–23.2],p=0.035;ORadj 8.1 [1.8–45.8],p=0.010)。
  • 人工智能聚类可将异质性ICU队列分为4个临床特征和活动参数显著不同的簇。
  • 不同簇对应不同活动策略以支持回家出院可能性,实现个体化且资源优化的活动方案。

适用人群与场景

  • 德国慕尼黑两个跨学科ICU的前瞻性观察数据库中的948例患者,纳入时间为2017年4月至2019年5月。

处置流程与药物剂量

  • 活动剂量由每日活动次数、平均持续时间、早期活动以及达到的平均和最大活动等级确定。
  • 基于入ICU时收集的参数进行k-means聚类分析,生成临床可定义的簇。

研究设计与关键结果

  • 研究类型为前瞻性观察数据库分析,纳入948例患者,来自德国慕尼黑两个跨学科ICU。
  • 共识别4个簇:「年轻创伤」「重症衰弱」「老年非衰弱」「中年」。
  • 「年轻创伤」簇中,早期活动(<72 h)是回家出院的最重要因素(ORadj 10.0 [2.8–44.0],p<0.001)。
  • 「中年」簇中,回家出院可能性随每个活动等级增加,步行时最大增至24倍(ORadj 24.0 [7.4–86.1],p<0.001)。
  • 「老年非衰弱」簇中,达到站立或步行时回家出院可能性显著增加(ORadj 4.7 [1.2–23.2],p=0.035;ORadj 8.1 [1.8–45.8],p=0.010)。

证据类型、等级与局限

  • 证据类型:前瞻性观察数据库分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于人工智能的学习方法可将异质性危重症队列分为4个簇,不同簇采用不同活动策略以支持回家出院可能性,从而实现个体化且资源优化的活动方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While early mobilization is commonly implemented in intensive care unit treatment guidelines to improve functional outcome, the characterization of the optimal individual dosage (frequency, level or duration) remains unclear. The aim of this study was to demonstrate that artificial intelligence-based clustering of a large ICU cohort can provide individualized mobilization recommendations that have a positive impact on the likelihood of being discharged home.

METHODS: This study is an analysis of a prospective observational database of two interdisciplinary intensive care units in Munich, Germany. Dosage of mobilization is determined by sessions per day, mean duration, early mobilization as well as average and maximum level achieved. A k-means cluster analysis was conducted including collected parameters at ICU admission to generate clinically definable clusters.

RESULTS: Between April 2017 and May 2019, 948 patients were included. Four different clusters were identified, comprising "Young Trauma," "Severely ill & Frail," "Old non-frail" and "Middle-aged" patients. Early mobilization (< 72 h) was the most important factor to be discharged home in "Young Trauma" patients (ORadj 10.0 [2.8 to 44.0], p < 0.001). In the cluster of "Middle-aged" patients, the likelihood to be discharged home increased with each mobilization level, to a maximum 24-fold increased likelihood for ambulating (ORadj 24.0 [7.4 to 86.1], p < 0.001). The likelihood increased significantly when standing or ambulating was achieved in the older, non-frail cluster (ORadj 4.7 [1.2 to 23.2], p = 0.035 and ORadj 8.1 [1.8 to 45.8], p = 0.010).

CONCLUSIONS: An artificial intelligence-based learning approach was able to divide a heterogeneous critical care cohort into four clusters, which differed significantly in their clinical characteristics and in their mobilization parameters. Depending on the cluster, different mobilization strategies supported the likelihood of being discharged home enabling an individualized and resource-optimized mobilization approach.

TRIAL REGISTRATION: Clinical Trials NCT03666286, retrospectively registered 04 September 2018.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Fuest KE, Ulm B, Daum N, et al. Clustering of critically ill patients using an individualized learning approach enables dose optimization of mobilization in the ICU. Crit Care. 2023. PMID: 36597110. doi:10.1186/s13054-022-04291-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。